ArticlePLoS neglected tropical diseases2018
Geospatial-temporal distribution of Tegumentary Leishmaniasis in Colombia (2007-2016).
Article in PLoS neglected tropical diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 44 citations in OpenAlex.
- Co-circulation of Trypanosoma cruzi and Leishmania spp. in Northwestern Colombia, a major migratory corridor.PLoS neglected tropical diseases · 2026Article
- Climatic, socioeconomic, and migratory factors on the epidemiological dynamics of cutaneous leishmaniasis in Colombia, 2007-2021.PLoS neglected tropical diseases · 2025Article
- Skin mycosis distribution, and burden of visits over a decade in Colombia: ecological study.IJID regions · 2024Article
- Spatio-Temporal distribution of a vector of cutaneous leishmaniasis: Pintomyia longiflocosa, in a population from the Colombian Andean Mountains.PLoS neglected tropical diseases · 2024Article
- The Impact of Climatological Factors on the Incidence of Cutaneous Leishmaniasis (CL) in Colombian Municipalities from 2017 to 2019.Pathogens (Basel, Switzerland) · 2024Article
- Prokaryotic and eukaryotic skin microbiota modifications triggered by Leishmania infection in localized Cutaneous Leishmaniasis.PLoS neglected tropical diseases · 2024Article
- Validation of Oxford nanopore sequencing for improved New World Leishmania species identification via analysis of 70-kDA heat shock protein.Parasites & vectors · 2023Article
- Ensuring access to essential health products: Lessons from Colombia's leishmaniasis control and elimination initiative.PLoS neglected tropical diseases · 2023Review
- Space-time patterns and associated factors of leishmaniasis in Colombia, 2008-2016.Revista de salud publica (Bogota, Colombia) · 2023Article
- Sequencing of hsp70 for discernment of species from the Leishmania (Viannia) guyanensis complex from endemic areas in Colombia.Parasites & vectors · 2022Article
- Spatial and Temporal Variability of Visceral Leishmaniasis in Colombia, 2007 to 2018.The American journal of tropical medicine and hygiene · 2021Article
- Spatiotemporal distribution of cutaneous leishmaniasis in Sri Lanka and future case burden estimates.PLoS neglected tropical diseases · 2021Article
- Adaptation and performance of a mobile application for early detection of cutaneous leishmaniasis.PLoS neglected tropical diseases · 2021Article
- Complex ecological interactions across a focus of cutaneous leishmaniasis in Eastern Colombia: novel description ofRoyal Society open science · 2020Article
- Temporal lagged relationship between a vegetation index and cutaneous leishmaniasis cases in Colombia: an analysis implementing a distributed lag nonlinear model.Parasitology research · 2020Article
- Ecological niche modelling for predicting the risk of cutaneous leishmaniasis in the Neotropical moist forest biome.PLoS neglected tropical diseases · 2019Article
- Cutaneous Leishmaniasis: The Complexity of Host's Effective Immune Response against a Polymorphic Parasitic Disease.Journal of immunology research · 2019Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTegumentary Leishmaniasis (TL) is a neglected disease with worldwide distribution and considered a public health problem, especially in Latin America. In Colombia, the governmental epidemiological surveillance system (SIVIGILA) is responsible for collecting information on the presentation of cases of TL from each of the municipalities and departments. In absence of a study compiling and analyzing currently available metadata of TL in Colombia, this study describes the geospatial-temporal distribution of TL and identifies the regions of the country on which prevention measures should be established in order to control the disease. METHODOLOGY/PRINCIPAL
findingsThis is an exploratory descriptive analysis of the distribution of TL in Colombia. Information was collected on new cases of the disease during the years 2007-2016 from the Colombian reporting system (SIVIGILA). Incidence calculations were made based on population estimates by departments and biogeographical regions. Time evolution is shown in biennial maps. A 10-year series was analyzed, showing that the Amazon region is the most affected in terms of incidence, while the Andean region has the highest number of cases with a high variability among the departments that make it up. In those departments where there is a greater reported diversity of vector species, a large number of cases was observed. CONCLUSIONS/SIGNIFICANCE: Transmission dynamics of TL in Colombia in the past 10 years have been variable, with a greater concentration of cases in the central and southern departments. The present study contributes to improve the understanding of the patterns of distribution of TL in Colombia and can be a basis for future studies of impact evaluation of Health policies in the country and the region.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.